EMEA-001071-PIP03-14-M01

Key facts

Invented name
Cimzia
Active substance
Certolizumab pegol
Therapeutic area
Dermatology
Decision number
P/0397/2018
PIP number
EMEA-001071-PIP03-14-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UCB Pharma S.A.

E-mail: medinfone@ucb.com
Tel. +32 2559 9999

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating